Skip to main content
Fig. 2 | BMC Endocrine Disorders

Fig. 2

From: Hypereosinophilia is a predictive biomarker of immune checkpoint inhibitor-induced hypopituitarism in patients with renal cell carcinoma

Fig. 2

Distribution of white blood cell count (A), fraction of eosinophil (B), and eosinophil count (C) at baseline (BT), last visit (LV), and onset of symptoms (OT). Eosinophil fraction (%) and eosinophil count were significantly higher at LV and OT than at BT. Data were expressed as scatter plots with a bar (mean ± standard error of the mean). *p < 0.05, after post hoc analysis

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us